Update on the Treatment of Trichotillomania
November 2024
in “
Actas Dermo-Sifiliográficas
”
Studysummary This review outlines current treatment strategies for trichotillomania, noting that while cognitive-behavioral therapy is effective, N-acetylcysteine and memantine are also recommended due to their safety and efficacy, though evidence for other drugs like fluoxetine and naltrexone remains limited.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
Trichotillomania (TTM) is an obsessive-compulsive disorder characterized by recurrent hair pulling, leading to hair loss or alopecia. Treating TTM is challenging and involves a combination of pharmacological and non-pharmacological methods. Cognitive-behavioral therapy is effective but not suitable for all patients. Alternative support tools like electronic devices, internet therapies, and microneedling are suggested. N-acetylcysteine and memantine are recommended as first-line treatments due to their safety and efficacy, with minimal adverse effects. Other drugs such as fluoxetine, clomipramine, olanzapine, and naltrexone show limited and variable efficacy. This review discusses current treatment options for managing TTM.